Christopher J. Sobecki - 28 Apr 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Christopher J. Sobecki
Issuer symbol
LXRX
Transactions as of
28 Apr 2023
Transactions value $
$0
Form type
4
Filing time
28 Apr 2023, 16:29:13
Previous filing
05 Apr 2023
Next filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Award $0 +8.03K $0.00 8.03K 28 Apr 2023 Common Stock 8.03K $0.00 Direct F1, F2
transaction LXRX Stock Option (Right to Buy) Award $0 +12.7K $0.00 12.7K 28 Apr 2023 Common Stock 12.7K $2.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.